Ameriprise
IDYA icon

Ameriprise’s IDEAYA Biosciences IDYA Stock Holding History

Ameriprise’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.51M Buy
45,263
+309
+0.7% +$10.4K ﹤0.01% 3098
2025
Q4 		$1.55M Buy
44,954
+74
+0.2% +$2.36K ﹤0.01% 3129
2025
Q3 		$1.22M Buy
44,880
+4,430
+11% +$107K ﹤0.01% 3256
2025
Q2 		$850K Sell
40,450
-228,614
-85% -$4.39M ﹤0.01% 3335
2025
Q1 		$4.41M Sell
269,064
-18,938
-7% -$403K ﹤0.01% 2408
2024
Q4 		$7.4M Buy
288,002
+10,072
+4% +$285K ﹤0.01% 2044
2024
Q3 		$8.8M Buy
277,930
+213,018
+328% +$8.08M ﹤0.01% 1910
2024
Q2 		$2.28M Sell
64,912
-148,602
-70% -$5.88M ﹤0.01% 2805
2024
Q1 		$9.37M Sell
213,514
-10,627
-5% -$457K ﹤0.01% 1842
2023
Q4 		$7.97M Sell
224,141
-49,332
-18% -$1.47M ﹤0.01% 1982
2023
Q3 		$7.38M Buy
273,473
+31,312
+13% +$794K ﹤0.01% 1952
2023
Q2 		$5.69M Sell
242,161
-191,521
-44% -$3.94M ﹤0.01% 2244
2023
Q1 		$5.95M Buy
433,682
+23,112
+6% +$385K ﹤0.01% 2196
2022
Q4 		$7.46M Buy
410,570
+348,005
+556% +$5.85M ﹤0.01% 1999
2022
Q3 		$933K Sell
62,565
-1,913
-3% -$24.8K ﹤0.01% 3142
2022
Q2 		$889K Buy
64,478
+2,937
+5% +$32.7K ﹤0.01% 3166
2022
Q1 		$688K Sell
61,541
-2,100
-3% -$31K ﹤0.01% 3361
2021
Q4 		$1.5M Buy
63,641
+48,421
+318% +$1.12M ﹤0.01% 3068
2021
Q3 		$388K Hold
15,220
– – ﹤0.01% 3485
2021
Q2 		$319K Hold
15,220
– – ﹤0.01% 3617
2021
Q1 		$358K Hold
15,220
– – ﹤0.01% 3530
2020
Q4 		$213K Buy
15,220
+110
+0.7% +$1.49K ﹤0.01% 3607
2020
Q3 		$190K Buy
+15,110
New +$187K ﹤0.01% 3553

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Ameriprise's IDYA Position: Q1 2026 in Review

Ameriprise increased its IDEAYA Biosciences (IDYA) stake by 0.69% in Q1 2026, buying an estimated $10.4K and bringing the position to 45,263 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #3098.

Ameriprise first reported a position in IDYA in Q3 2020 and has held it in 23 quarters since. The position peaked at $9.37M in Q1 2024. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Ameriprise held 45,263 shares of IDEAYA Biosciences worth $1.51M as of Q1 2026.
  • Ameriprise bought 309 IDEAYA Biosciences shares in Q1 2026, an estimated $10.4K.
  • IDEAYA Biosciences made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3098 holding.
  • Ameriprise first reported a position in IDEAYA Biosciences in Q3 2020 and has held it in 23 quarters since.
  • Ameriprise's IDEAYA Biosciences position peaked at $9.37M in Q1 2024.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.